{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:47:18Z","timestamp":1768434438383,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.1038\/s41416-019-0536-0","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T23:03:43Z","timestamp":1566255823000},"page":"513-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Solid cancer: the new tumour spread endpoint opens novel opportunities"],"prefix":"10.1038","volume":"121","author":[{"given":"Michael","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rosel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-7299","authenticated-orcid":false,"given":"Jan","family":"Br\u00e1bek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"536_CR1","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1056\/NEJMp1805966","volume":"378","author":"JA Beaver","year":"2018","unstructured":"Beaver, J. A., Kluetz, P. G. & Pazdur, R. Metastasis-free Survival\u2014a new end point in prostate cancer trials. N. Engl. J. Med. 378, 2458\u20132460 (2018).","journal-title":"N. Engl. J. Med."},{"key":"536_CR2","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration. Draft Guidance. Nonmetastatic, castration resistant prostate cancer: considerations for metastasis-free survival endpoint in clinical trials. 2018. https:\/\/www.fda.gov\/media\/117792\/download"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","volume":"378","author":"MR Smith","year":"2018","unstructured":"Smith, M. R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B. A., Graff, J. N. et al. for the SPARTAN investigators. Apalutamide treatment and metastasis-free survival in prostate cancer. N. Engl. J. Med 378, 1408\u20131418 (2018).","journal-title":"N. Engl. J. Med"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","volume":"378","author":"M Hussain","year":"2018","unstructured":"Hussain, M., Fizazi, K., Saad, F., Rathenborg, P., Shore, N., Ferreira, U. et al. Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer. N. Engl. J. Med. 378, 2465\u20132474 (2018).","journal-title":"N. Engl. J. Med."},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","volume":"380","author":"K Fizazi","year":"2019","unstructured":"Fizazi, K., Shore, N., Tammela, T. L., Ulys, A., Vjaters, E., Polyakov, S. et al. Darolutamide in nonmetastatic, castration-resistant prostate cancer. N. Engl. J. Med. 380, 1235\u20131246 (2019).","journal-title":"N. Engl. J. Med."},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2147\/OTT.S103832","volume":"9","author":"J Br\u00e1bek","year":"2016","unstructured":"Br\u00e1bek, J., Rosel, D. & Fernandes, M. Pragmatic medicine in solid cancer: a translational alternative to precision medicine. Onco Targets Ther. 9, 1839\u20131855 (2016).","journal-title":"Onco Targets Ther."},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","volume":"3","author":"A Gandalovi\u010dov\u00e1","year":"2017","unstructured":"Gandalovi\u010dov\u00e1, A., Rosel, D., Fernandes, M., Vesel\u00fd, P., Heneberg, P., \u010cerm\u00e1k, V. et al. Migrastatics-anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer 3, 391\u2013406 (2017).","journal-title":"Trends Cancer"},{"key":"536_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","volume":"8","author":"RR Weichselbaum","year":"2011","unstructured":"Weichselbaum, R. R. & Hellman, S. Oligometastases revisited. Nat. Rev. Clin. Oncol. 8, 378\u2013382 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2016.11.003","volume":"52","author":"JC Hong","year":"2017","unstructured":"Hong, J. C. & Salama, J. K. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going? Cancer Treat. Rev. 52, 22\u201332 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1021\/acs.jmedchem.9b00335","volume":"62","author":"L Leung","year":"2019","unstructured":"Leung, L., Niculescu-Duvaz, D., Smithen, D., Lopes, F., Callens, C., McLeary, R. et al. Anti-metastatic inhibitors of lysyl oxidase (LOX): design and structure-activity relationships. J. Med. Chem. 62, 5863\u20135884 (2019).","journal-title":"J. Med. Chem."},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41571-019-0169-5","volume":"16","author":"M Gerwing","year":"2019","unstructured":"Gerwing, M., Herrmann, K., Helfen, A., Schliemann, C., Berdel, W. E., Eisenbl\u00e4tter, M. et al. The beginning of the end for conventional RECIST\u2014novel therapies require novel imaging approaches. Nat. Rev. Clin. Oncol. 16, 442\u2013458 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"536_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","volume":"5","author":"Wolfgang P. Fendler","year":"2019","unstructured":"Fendler, W. P., Calais, J., Eiber, M., Flavell, R. R., Mishoe, A., Feng, F. Y. et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate Cancer. A prospective single-arm clinical trial. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0096","journal-title":"JAMA Oncology"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.urology.2019.04.004","volume":"130","author":"Manuela A. Hoffmann","year":"2019","unstructured":"Hoffmann, M. A., Wieler, H. J., Baues, C., Kuntz, N. J., Richardsen, I. & Schreckenberger, M. The impact of 68Ga-PSMA PET\/CT and PET\/MRI on the management of prostate cancer. Urology. 2019. https:\/\/doi.org\/10.1016\/j.urology.2019.04.004","journal-title":"Urology"},{"key":"536_CR14","first-page":"32","volume":"1","author":"J Br\u00e1bek","year":"2012","unstructured":"Br\u00e1bek, J. & Fernandes, M. Affordable cancer care. Lancet Oncol. 1, 32\u201333 (2012).","journal-title":"Lancet Oncol."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0536-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0536-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0536-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T18:09:26Z","timestamp":1655316566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0536-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10,1]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0536-0","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"J.B. and D.R. are supported by the Ministry of Education, Youth and Sports of CR within the LQ1604 National Sustainability Program II (Project BIOCEV-FAR), and by project \u2018Center for Tumor Ecology\u2014Research of the Cancer Microenvironment Supporting Cancer Growth and Spread\u2019 (reg. no. CZ.02.1.01\/0.0\/0.0\/16_019\/0000785) supported by the Operational Programme Research, Development and Education.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0)","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}